5 changes that should be made in oncology
from Managed Healthcare Executive
COVID-19 is certainly important. But oncologists, people with cancer, and complex ecosystem of cancer care in the U.S. are grappling with other important issues as well — reimbursement, distorted incentives, the implications of the massive amount of data that is available and high costs and prices. Below are thoughts from five experts on these challenges and how they might be met.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063